Is CCL18 a potential biomarker of type-2 asthma?

Publié en janvier 2020 EUROPEAN RESPIRATORY JOURNAL

The burden of emphysema on lung cancer prognosis

EUROPEAN RESPIRATORY JOURNAL

Publication précédente

The first-in-human study of CNTO 7160, an anti-interleukin-33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis

EUROPEAN RESPIRATORY JOURNAL

Publication suivante